Skip to main content

AI Model Reduces False Positives in Screening Mammograms

Medically reviewed by Carmen Pope, BPharm. Last updated on April 25, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, April 25, 2024 -- A semiautonomous breast cancer screening system reduces false positives with screening mammograms, according to a study published online April 10 in Radiology: Artificial Intelligence.

Stefano Pedemonte, Ph.D., from Whiterabbit.ai in Santa Clara, California, and colleagues evaluated the ability of a semiautonomous artificial intelligence (AI) model to identify screening mammograms not suspicious for breast cancer. The analysis compared performance of humans and AI using three nonoverlapping datasets of 14,831 screening mammography examinations (1,026 cancers).

The researchers found minimal changes to the cancer detection rate with use of the AI device (noninferiority margin of 0.25 cancers per 1,000 examinations). For U.S. dataset 1 (11,592 mammograms; 101 cancers), the AI model reduced screening examinations requiring radiologist interpretation by 41.6 percent, diagnostic examination callbacks by 31.1 percent, and benign needle biopsies by 7.4 percent. For U.S. dataset 2 (1,362 mammograms; 330 cancers), reductions were 19.5, 11.9, and 6.5 percent, respectively. For the U.K. dataset (1,877 mammograms; 595 cancers), reductions were 36.8, 17.1, and 5.9 percent, respectively.

"This work demonstrates the potential of a semiautonomous breast cancer screening system to reduce false positives, unnecessary procedures, patient anxiety, and medical expenses," the authors write.

Several authors disclosed financial ties to Whiterabbit.ai.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted April 2024

Read this next

Sociodemographics Tied to Rehab Use During Critical Illness Hospitalization

FRIDAY, May 10, 2024 -- For older adults hospitalized with a stay in the intensive care unit (ICU), social determinants of health (SDOH) are associated with use of skilled...

Breakthrough Gene Therapy Enables Infant Born Deaf to Hear

FRIDAY, May 10, 2024 -- Significant hearing improvements have been achieved in an infant with profound hearing loss due to a biallelic otoferlin gene (OTOF) mutation, according to...

Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure

FRIDAY, May 10, 2024 -- The Jarvik 2015 left ventricular assist device (LVAD) seems promising as an implantable continuous flow device for small children with severe systolic...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.